Abbott Laboratories Trading Volume Plummets 56.48% to 144th Position

On April 1, 2025, Abbott Laboratories (ABT) experienced a significant decline in trading volume, with a total turnover of $557 million, marking a 56.48% decrease from the previous day. This placed ABT at the 144th position in terms of trading volume for the day. The stock price of ABT also decreased by 0.72%.

Abbott Laboratories, a leading healthcare company, has been closely monitored by investors and analysts. The stock's performance has been influenced by various factors, including market conditions and company-specific developments. On April 1, 2025, the stock opened at $131.95, with the day's high reaching $132.63 and the low at $131.13. The previous close was recorded at $132.65, indicating a slight downward trend.

Investors are also keeping an eye on the company's financial health and future prospects. The 52-week range for ABT's stock price is between $99.71 and $141.23, reflecting the volatility in the market. The beta value of 0.69 suggests that the stock is less volatile compared to the overall market. Analysts have generally rated the stock as a buy, indicating a positive outlook for the company's future performance.